0001209191-21-042898.txt : 20210623 0001209191-21-042898.hdr.sgml : 20210623 20210623215243 ACCESSION NUMBER: 0001209191-21-042898 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210621 FILED AS OF DATE: 20210623 DATE AS OF CHANGE: 20210623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Gregory CENTRAL INDEX KEY: 0001329505 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 211040447 MAIL ADDRESS: STREET 1: 4 A CHESHAM STREET CITY: LONDON STATE: X0 ZIP: SW1X8DT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AgeX Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821436829 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 510-671-8370 MAIL ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-21 0 0001708599 AgeX Therapeutics, Inc. AGE 0001329505 Bailey Gregory C/O AGEX THERAPEUTICS, INC. 1101 MARINA VILLAGE PARKWAY, SUITE 201 ALAMEDA CA 94501 1 0 0 0 Option to Purchase Common Stock 1.48 2021-06-21 4 A 0 65000 0.00 A 2031-06-20 Common Stock 65000 65000 D Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter. /s/Gregory Bailey 2021-06-23